DAVITA INC. Amortization of Debt Issuance Costs
DAVITA INC. (DVA) reported Amortization of Debt Issuance Costs of $40.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-02-11
- DAVITA INC. amortization of debt issuance costs for fiscal 2025 was $40.00M, a 13.43% increase from fiscal 2024.
- DAVITA INC. amortization of debt issuance costs for fiscal 2024 was $35.27M, a 43.36% increase from fiscal 2023.
- DAVITA INC. amortization of debt issuance costs for fiscal 2023 was $24.60M, a 38.42% increase from fiscal 2022.
- DAVITA INC. amortization of debt issuance costs for fiscal 2022 was $17.77M, a 2.38% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|
| 2025-12-31 | $40.00M 10-K · filed 2026-02-11 | |
| 2024-12-31 | $35.27M 10-K · filed 2026-02-11 | |
| 2023-12-31 | $24.60M 10-K · filed 2026-02-11 | |
| 2022-12-31 | $17.77M 10-K · filed 2025-02-13 | |
| 2021-12-31 | $18.20M 10-K · filed 2024-02-14 | |
| 2020-12-31 | $21.18M 10-K · filed 2023-02-22 | |
| 2019-12-31 | $24.18M 10-K · filed 2022-02-11 | |
| 2018-12-31 | $25.54M 10-K · filed 2021-02-12 | |
| 2017-12-31 | $24.29M 10-K · filed 2020-02-21 | |
| 2016-12-31 | $20.10M 10-K · filed 2019-02-22 | |
| 2015-12-31 | $18.63M 10-K · filed 2018-02-23 | |
| 2014-12-31 | $24.54M 10-K · filed 2017-02-24 | |
| 2013-12-31 | $28.80M 10-K · filed 2016-02-26 | $24.93M 10-K · filed 2014-02-21 |
| 2012-12-31 | $18.45M 10-K · filed 2015-02-26 | $12.83M 10-K · filed 2013-03-01 |
| 2011-12-31 | $13.42M 10-K · filed 2014-02-21 | $10.14M 10-K · filed 2012-02-24 |
| 2010-12-31 | $9.34M 10-K · filed 2013-03-01 | |
| 2009-12-31 | $9.65M 8-K · filed 2012-07-06 | |
| 2008-12-31 | $9.77M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |